Bill · S. 2730· Senate(119-S-2730)
Kidney Care Access Protection Act
- Introduced
- 9/8/2025
- Last activity
- 9/8/2025 — Read twice and referred to the Committee on Finance.
- Sponsored by
- Marsha Blackburn
- Cosponsors
- - 1 - 1
- Introduced
- In Committee
What this bill would do
The Kidney Care Access Protection Act aims to amend title XVIII of the Social Security Act to improve access to innovative treatments for end-stage renal disease under Medicare. The bill extends the transitional drug add-on payment adjustment period for new renal dialysis drugs and biological products. It also establishes a permanent post-TDAPA add-on adjustment for these drugs and clarifies the definition of renal dialysis services. Additionally, the bill extends the period for transitional add-on payments for new and innovative equipment and supplies. Finally, it directs the Secretary to make direct payment adjustments for Medicare Advantage enrollees and addresses staffing barriers through labor adjustments.
Yes· 3 of 7
Would people over 65 be better off under this?+6
The bill enhances Medicare coverage for essential kidney care treatments and technologies used by seniors.
Would retired people be better off under this?+6
The bill improves the value and coverage of the Medicare program which many retirees rely on for life-sustaining care.
Does this make health care easier to get in general?+6
The bill improves access to innovative treatments and breakthrough medical devices for patients with end-stage renal disease.
The opposite
No question was scored the opposite.
Who it would affect, and how
Potential Positive Impacts for People
-
Improved access to new drugs: The bill extends the transitional drug add-on payment adjustment for new renal dialysis drugs or biological products approved by the FDA on or after January 1, 2020, for not less than 3 years (Section 101(a)).
-
Permanent coverage for innovative treatments: The Secretary will establish a permanent add-on adjustment for new renal dialysis drugs or biological products to ensure continued payment after the transitional period (Section 101(b)).
-
Expanded coverage for breakthrough devices: Devices designated for expedited development and priority review will be eligible for transitional add-on payments for new and innovative equipment and supplies (Section 101(d)).
-
Access to capital-related assets: The bill allows for the calculation of adjustments for capital-related assets that meet the requirements for new and innovative equipment (Section 101(d)).
-
Support for Medicare Advantage enrollees: The Secretary will make direct payment adjustments to providers for new drugs, biological products, or equipment/services used by Medicare Advantage enrollees with end-stage renal disease (Section 102(a)).
-
Addressing economic forecasting errors: The Secretary will compute a forecast error adjustment to account for differences between forecasted and actual price changes in goods and services related to renal dialysis (Section 201).
Potential Negative Impacts for People
- No specific negative impacts are explicitly detailed in the provided text.
Groups and Interests Ranking
Every group the model scored this bill for, from -10 to +10. Hover a score for the reason it gave.
- Demographic And Interest Groups
- Good For Retirees+6Good For Seniors+6Good For Low Income Households+2
- Healthcare
- Improves Healthcare Access+6Increases Medicare Funding+5
- Economy And Finance
- Improves Economic Growth+2
- Social Issues And Justice
- Improves Poverty Reduction+1
- 3/24/2026
- 1 Cosponsor added.
- 9/8/2025
- Read twice and referred to the Committee on Finance.
- 1 Cosponsor added.
- Introduced in Senate
One bill Congress.gov lists as related to this one — companions in the other chamber, earlier versions, and bills this one absorbed or was folded into.
Cory BookerDemocrat · New Jersey
Bill CassidyRepublican · Louisiana